Expression of CD44 variant proteins in adenocarcinoma of Barrett's esophagus and its relation to prognosis

Cancer

Volumn 83, Issue 6, 1998, Pages 1074-1080

  Böttger, Thomas C ^a   Youssef, Valentina ^a   Dutkowski, Phillip ^a   Maschek, Hans ^a   Brenner, Walpurga ^a   Junginger, Theo ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Adenocarcinoma; Barrett's esophagus; CD44 splice variants; Prognosis

Indexed keywords

HERMES ANTIGEN;

ADENOCARCINOMA; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; ESOPHAGUS CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; ANALYSIS OF VARIANCE; ANTIGENS, CD44; ANTIGENS, NEOPLASM; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED;

EID: 0032530514     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980915)83:6<1074::AID-CNCR4>3.0.CO;2-8     Document Type: Article

References (23)

1. B̈ttger T, Störkel S, Stöckle M, Wahl W, Jugenheimer M, Effenberger-Kim O, et al. DNA image cytometry: a prognostic tool in squamous cell carcinoma of esophagus? Cancer 1991;67:2290-4.
2. Matsumara Y, Tarin D. Significance of CD44 gene products cancer diagnosis and disease evaluation. Lancet 1992;340: 1053-8.
3. Joensuu H, Klemi PJ, Toikkanen S, Jalkanen S. Glycoprotein CD44 expression and its association with survival in breast cancer. Am J Pathol 1993;143:867-74.
4. Guo YJ, Liu G, Wang X. Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res 1994;54: 422-6.
5. Wielenga VJM, Heider KH, Offerhaus JA. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993;53:4754-6.
6. Mulder JWR, Kruyt PM, Sewnath M. Colorectal cancer prognosis and expression of exon v6-containing CD44 proteins. Lancet 1994;344:1470-2.
7. Jalkanen S, Bargatze RF, Herren LR, Butcher EC. Lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. Eur J Immunol 1986;16:1195-1202.
8. Finke LH, Zörb C, Haensch W, Schlag PM, Terpe HJ. Expression von CD44 Isoformen: ein neuer histopathologischer Parameter beim kolorektalen Karzinom? Zentralbl Chir 1996;121:450-4.
9. Gotley DC, Fawcett J, Walsh MD, Reeder JA, Simmons DL, Antalis TM. Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer. Br J Cancer 1996;74:342-51.
10. Koretz K, Möller P, Lehnert T, Hinz U, Otto H, Herfarth C. Effect of CD44v6 on survival in colorectal carcinoma. Lancet 1995;345:327-8.
11. Shan-Rong, Shim Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39:741-8.
12. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell J. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A 1992;89:12160-4.
13. G̈nthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haußmann, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991;65:13-24.
14. Heider KH, Dämmrich J, Skroch-Angel P, Müller-Hermelink HK, Vollmers HP, Herrlich P, et al. Differential expression of CD44-splice variants in intestinal-and diffuse-type human gastric carcinomas and normal gastric carcinomas and normal gastric mucosa. Cancer Res 1993;53:4197-203.
15. Castellà E, Ariza A, Fernández-Vasalo A, Roca X, Ojanguren I. Expression of CD44H and CD44v3 in normal oesophagus, Barrett mucosa and oesophageal carcinoma. J Clin Pathol 1996;49:489-92.
16. Rall JNC, Rustgi AK. CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma. Cancer Res 1995;55:1831-5.
17. Gansauge F, Gansauge S, Zobywalski A, Scharnweber C, Link KH, Nussler AK, et al. Differential expression of CD44 splice variants in human pancreatic adenocarcinoma and in normal pancreas. Cancer 1995;55:5499-503.
18. Roye GD, Russel BM, Brown D, Poczatek R, Beenken S, Grizzle WE. CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus. Int J Cancer 1996;69:254-8.
19. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with the extracellular matrix. Adv Immunol 1993;1:1-8.
20. Kaufmann M, Heider KH, Sinn HP, v Minckwitz G, Ponta H, Herrlich P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995;345:615.
21. Smith CW, Patton JG, Nadal GB. Alternative splicing in the control of gene expression. Annu Rev Genet 1989;23:527.
22. Böttger T, Youssef V, Dutkowski P, Maschek H, Brenner W, Junginger T. Prognostic significance of CD44 splice variants in squamous cell carcinoma of the esophagus: a multivariate approach. In press.
23. Salmi M, Gron-Virta K, Sointu P, Grenman R, Kalimo H, Jalkanan S. Regulated expression of exon v6 containing isoforms of CD44 in man: dowregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol 1993;122:431.